Speaker illustration

Professor Andrew Stewart Coats

Heart Research Institute, Sydney (Australia)

Member of:

Heart Failure Association

Andrew was born in Melbourne, Australia and studied Medicine at Oxford and Cambridge. He has published over 20 patents and 750 papers with 160,000 career citations, and an H-index of 160. He served as Editor-in-Chief of the International Journal of Cardiology from 1999 to 2016. Andrew is an expert on heart failure. He first described the Muscle Hypothesis of Chronic Heart Failure that explained dyspnoea and exaggerated ventilatory responses in CHF patients. He first described chemoreflex overactivity as cause of periodic breathing in CHF and published the first ever randomised trial of exercise training for CHF. Andrew has been Chairman or Committee member of the following major Cardiovascular and Cancer Cachexia Clinical Trials: CHRISTMAS, CHARM, COPERNICUS, OXAM, OPTIMAAL, OVERTURE, REPLACE, SENIORS, AUGMENTHF and ACT-ONE. He was Head of Cardiology at Imperial College, London and Dean of Medicine at the University of Sydney. He was President of the Heart Failure Association 2020-22.

Frailty in heart failure

Event: Heart Failure 2024

Topic: Cardio-Oncology

Session type: Symposium

Thumbnail

A new era in the management of patients with heart failure: the role of non-steroidal MRAs

Event: Heart Failure 2024

Topic: Cardiovascular Pharmacotherapy

Session type: Satellite Symposium

Thumbnail

Unlocking the potential of baroreflex activation therapy (BAT) for HFrEF patients

Event: ESC Congress 2022

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session type: Satellite Symposium

Thumbnail

Heart failure and secondary mitral regurgitation: all you need to know

Event: ESC Congress 2022

Topic: Chronic Heart Failure

Session type: Symposium

Thumbnail

Personalized approach in real-world heart failure management: are we ready for the revolution?

Event: ESC Congress 2022

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Thumbnail

Cardiac contractility modulation: a proven device-based therapeutic approach to reduce hospitalizations and improve quality of life for patients with heart failure

Event: ESC Congress 2022

Topic: Device Treatment

Session type: Satellite Symposium

Thumbnail

Heart Failure 2022 highlights

Event: Heart Failure 2022

Topic: Heart Failure Association (HFA)

Session type: Special Session

Thumbnail

Lifetime Achievement Award 2022

Event: Heart Failure 2022

Topic: Heart Failure Association (HFA)

Session type: Special Session

Thumbnail

The year's best papers on heart failure

Event: Heart Failure 2022

Topic: Heart Failure Association (HFA)

Session type: Special Session

Thumbnail

Optimizing foundational therapies in patients with heart failure: from evidence to real-world clinical practice

Event: Heart Failure 2022

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Thumbnail